DAPP1 and acute myeloid leukemia: Across diverse datasets—including human hematopoiesis, acute myeloid leukemia, mouse endocrinogenesis, Dapp1 knockout and irradiation injury—scRL outperformed benchmark fate-inference and pseudotime methods, revealed novel regulators and mapped dynamic fate biases (see Results, Figure 1, Figure 2, Figure 3, Figure 4, Figure 5, Figure 6, Figure 7, Figure 8, Figure 9 and Figure 10).